Search research articles
Contact Us
Filters
Showing results (191-200 of 311) with videos related to
Page
of 32
Sort By:
Frontiers in Oncology
|
December 6, 2021
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
Ahmad Najem, Jasper Wouters, Mohammad Krayem, et al.
Cancers
|
August 29, 2024
Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer
Noémie Thomas, Soizic Garaud, Mireille Langouo, et al.
Cancers
|
December 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093
Mohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane
Peter A Kaufman, Ahmad Awada, Chris Twelves, et al.
Acta Clinica Belgica
|
January 6, 2019
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results
Gaetan Catala, Jeroen Mebis, Guy Jerusalem, et al.
Case Reports in Oncology
|
March 25, 2025
Metastatic Gestational Trophoblastic Neoplasia Leading to Acute Respiratory Failure and Death: A Case Report - About a Particularly Challenging Management in the Intensive Care Unit, and Exploring the Potential of Pembrolizumab in Treating Frail, Pretreated Gestational Trophoblastic Neoplasia
Michel Meyers, Ahmad Awada, Marine Najmaoui, et al.
The Oncologist
|
May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors
Dirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2016
p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib
Mohammad Krayem, Fabrice Journe, Murielle Wiedig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 28, 2007
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics
Ahmad Awada, Fatima Cardoso, Christel Fontaine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approach
Eric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Page
of 32
Search research articles
Search
Showing results (191-200 of 311) with videos related to
Sort By:
Page
of 32
Frontiers in Oncology
|
December 6, 2021
Tyrosine-Dependent Phenotype Switching Occurs Early in Many Primary Melanoma Cultures Limiting Their Translational Value
Ahmad Najem, Jasper Wouters, Mohammad Krayem, et al.
Cancers
|
August 29, 2024
Tumor-Infiltrating Lymphocyte Scoring in Neoadjuvant-Treated Breast Cancer
Noémie Thomas, Soizic Garaud, Mireille Langouo, et al.
Cancers
|
December 23, 2023
Correction: Krayem et al. The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma. <i>Cancers</i> 2019, <i>11</i>, 1093
Mohammad Krayem, Malak Sabbah, Ahmad Najem, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 22, 2015
Phase III open-label randomized study of eribulin mesylate versus capecitabine in patients with locally advanced or metastatic breast cancer previously treated with an anthracycline and a taxane
Peter A Kaufman, Ahmad Awada, Chris Twelves, et al.
Acta Clinica Belgica
|
January 6, 2019
Neutropenia management in patients receiving myelosuppressive polychemotherapy for early breast cancer in Belgium: BRONS study results
Gaetan Catala, Jeroen Mebis, Guy Jerusalem, et al.
Case Reports in Oncology
|
March 25, 2025
Metastatic Gestational Trophoblastic Neoplasia Leading to Acute Respiratory Failure and Death: A Case Report - About a Particularly Challenging Management in the Intensive Care Unit, and Exploring the Potential of Pembrolizumab in Treating Frail, Pretreated Gestational Trophoblastic Neoplasia
Michel Meyers, Ahmad Awada, Marine Najmaoui, et al.
The Oncologist
|
May 2, 2007
Safety, pharmacokinetics, and preliminary antitumor activity of sorafenib: a review of four phase I trials in patients with advanced refractory solid tumors
Dirk Strumberg, Jeffrey W Clark, Ahmad Awada, et al.
European Journal of Cancer (Oxford, England : 1990)
|
January 21, 2016
p53 Reactivation by PRIMA-1(Met) (APR-246) sensitises (V600E/K)BRAF melanoma to vemurafenib
Mohammad Krayem, Fabrice Journe, Murielle Wiedig, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 28, 2007
The oral mTOR inhibitor RAD001 (everolimus) in combination with letrozole in patients with advanced breast cancer: results of a phase I study with pharmacokinetics
Ahmad Awada, Fatima Cardoso, Christel Fontaine, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 11, 2024
Treating cancer-associated venous thromboembolism: A practical approach
Eric Van Cutsem, Isabelle Mahé, Enriqueta Felip, et al.
Page
of 32